Treatment Options for Abnormal DXA Scan Results
The primary treatment for patients with abnormal DXA scan results should include bisphosphonates as first-line therapy, along with calcium and vitamin D supplementation, lifestyle modifications, and regular follow-up monitoring. 1, 2
Diagnosis and Classification
- DXA (Dual-Energy X-ray Absorptiometry) is the gold standard for diagnosing osteoporosis and is recommended for all women 65 years and older, as well as postmenopausal women younger than 65 with risk factors 1
- Osteoporosis is defined as a T-score of -2.5 or less, while osteopenia (low bone mass) is defined as a T-score between -1.0 and -2.5 1
- Risk factors for osteoporotic fracture include increasing age, female sex, postmenopausal status, low body weight, history of parental hip fracture, previous fracture, rheumatoid arthritis, smoking, alcohol intake, and long-term use of certain medications (especially glucocorticoids) 2
Treatment Recommendations Based on DXA Results
For Patients with Osteoporosis (T-score ≤ -2.5):
- Bisphosphonates are strongly recommended as first-line therapy for adults with high or very high fracture risk 3, 2
- Oral bisphosphonates are preferred due to their proven efficacy in reducing total and vertebral fractures and increasing hip and lumbar spine BMD 3
- For patients at very high fracture risk, parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) analogs may be considered over anti-resorptives (bisphosphonates or denosumab) 3
- Denosumab is an option for patients with high fracture risk who cannot tolerate bisphosphonates 1
- Teriparatide should be reserved for patients with severe osteoporosis or those who have had fractures 1
For Patients with Osteopenia (T-score between -1.0 and -2.5):
- Treatment decisions should be based on fracture risk assessment using FRAX (Fracture Risk Assessment Tool) 1, 2
- Pharmacologic treatment should be considered in women with a 10-year risk of major osteoporotic fracture of at least 20% or a risk of hip fracture of at least 3% 1
- Treatment should also be considered in patients who have had a low-trauma fracture, even if DXA does not indicate osteoporosis 1, 4
Calcium and Vitamin D Supplementation
- All patients should receive calcium and vitamin D supplementation based on age 1:
- Ages 19-50: 1,000 mg calcium, 600 IU vitamin D daily
- Ages 51-70: 1,200 mg calcium, 600 IU vitamin D daily
- Ages 71+: 1,200 mg calcium, 800 IU vitamin D daily
- Serum vitamin D levels should be maintained at ≥20 ng/mL (50 nmol/L) for good bone health 1
- For patients on glucocorticoid therapy, vitamin D levels should be maintained at ≥30-50 ng/mL 3
Monitoring Treatment Response
- The American College of Physicians recommends against bone density monitoring during the 5-year pharmacological treatment period for osteoporosis in women due to low-quality evidence 2
- However, more recent guidelines suggest follow-up BMD testing to monitor response to therapy 5
- Follow-up BMD testing should be performed if a fracture has occurred or new risk factors have developed 5
- Shorter intervals between BMD testing may be indicated for patients on medications associated with rapid bone loss (glucocorticoids, aromatase inhibitors, androgen deprivation therapy) 5
Special Considerations
For Patients on Glucocorticoid Therapy:
- Patients on glucocorticoids ≥2.5 mg/day for >3 months should receive osteoporosis therapy if at high or very high fracture risk 3
- Yearly clinical fracture risk assessment is recommended for these patients 3
- BMD testing should be performed every 1-2 years, with more frequent monitoring for very high-risk patients 3
For Patients Receiving Denosumab:
- Serum calcium should be measured before starting denosumab, as hypocalcemia is a common side effect 6
- Vitamin D levels should be evaluated before starting therapy 6
- Regular monitoring of serum calcium is necessary, especially after the first few doses 6
- A baseline dental assessment is mandatory before initiating denosumab to reduce the risk of osteonecrosis of the jaw 6
Lifestyle Modifications
- Weight-bearing and resistance exercises are recommended to optimize bone density 3, 1
- Smoking cessation and limiting alcohol to ≤2 servings per day 3
- Maintaining weight in the recommended range 3
- Fall prevention strategies should be implemented, particularly in elderly patients 4
Common Pitfalls to Avoid in DXA Interpretation
- Artifacts in the lumbar spine (such as osteoarthritis, aortic calcifications) can cause spurious increases in BMD values 5
- Incorrect positioning of the patient can lead to inaccurate measurements 5
- Vertebral fractures may show increased BMD due to trabecular impaction and condensation 5
- Hip prostheses or osteosynthesis hardware make the site unsuitable for diagnostic purposes 5
- Failure to exclude vertebrae affected by significant structural changes or differing by more than a T-score of 1.0 from adjacent vertebrae 5
By following these evidence-based recommendations, clinicians can effectively manage patients with abnormal DXA scan results to reduce fracture risk and improve bone health.